| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 336,4 k € | +41.1% | 238,4 k € | +13.0% | 211,0 k € | +7.8% | 195,8 k € | +15.2% | 170,0 k € | -2.8% | 174,9 k € | -12.0% | 198,7 k € | -1.0% | 200,7 k € | -5.2% | 211,7 k € | +0.1% | 211,5 k € | +2.9% | 205,4 k € | +5.8% | 194,3 k € | +6.0% | 183,3 k € | +6.3% | 172,4 k € | +12.2% | 153,6 k € | -6.8% | 164,9 k € | +10.3% | 149,5 k € | +3.0% | 145,1 k € | -42.9% | 254,1 k € | |
| EBITDA | 331,1 k € | +53.7% | 215,4 k € | +3.0% | 209,1 k € | +7.8% | 193,9 k € | +15.7% | 167,6 k € | -2.9% | 172,5 k € | -11.7% | 195,3 k € | -1.5% | 198,3 k € | -4.7% | 208,2 k € | -0.4% | 209,0 k € | +3.0% | 203,0 k € | +5.8% | 191,9 k € | +6.4% | 180,4 k € | +5.6% | 170,7 k € | +12.1% | 152,3 k € | -7.1% | 164,1 k € | +12.3% | 146,1 k € | +1.3% | 144,2 k € | -43.1% | 253,4 k € | |
| Operating profit | 320,2 k € | +53.3% | 208,8 k € | +2.8% | 203,1 k € | +8.1% | 188,0 k € | +16.0% | 162,0 k € | -3.0% | 167,0 k € | -12.0% | 189,8 k € | -1.5% | 192,8 k € | -4.1% | 200,9 k € | +26.4% | 159,0 k € | +3.9% | 153,0 k € | +7.9% | 141,8 k € | +11.2% | 127,6 k € | +11.3% | 114,6 k € | +13.6% | 101,0 k € | -10.3% | 112,6 k € | +6.4% | 105,8 k € | -3.9% | 110,1 k € | -52.8% | 233,0 k € | |
| Profit/loss | 225,7 k € | +31.8% | 171,2 k € | +11.8% | 153,1 k € | +8.2% | 141,5 k € | +20.4% | 117,5 k € | -3.9% | 122,3 k € | -7.6% | 132,4 k € | +10.8% | 119,5 k € | -1.6% | 121,5 k € | +14.4% | 106,2 k € | -6.6% | 113,6 k € | +9.8% | 103,5 k € | +12.9% | 91,7 k € | +16.5% | 78,7 k € | +15.4% | 68,2 k € | -10.7% | 76,3 k € | +5.5% | 72,4 k € | -4.6% | 75,9 k € | -51.1% | 155,2 k € | |
| Equity | 1,4 M € | +19.4% | 1,2 M € | +4.7% | 1,1 M € | -6.0% | 1,2 M € | +3.1% | 1,1 M € | +11.4% | 1,0 M € | +13.5% | 906,4 k € | -25.9% | 1,2 M € | +10.8% | 1,1 M € | +12.4% | 983,0 k € | +12.1% | 876,9 k € | +14.9% | 763,3 k € | +7.5% | 709,8 k € | +14.8% | 618,1 k € | +14.6% | 539,4 k € | +14.8% | 469,8 k € | +19.4% | 393,4 k € | +22.5% | 321,0 k € | +30.9% | 245,2 k € | |
| Total assets | 1,5 M € | +19.4% | 1,3 M € | -16.9% | 1,6 M € | +8.8% | 1,4 M € | +7.3% | 1,3 M € | -16.3% | 1,6 M € | +7.8% | 1,5 M € | +4.8% | 1,4 M € | +8.3% | 1,3 M € | +9.3% | 1,2 M € | +3.0% | 1,2 M € | +2.1% | 1,1 M € | +4.5% | 1,1 M € | +7.5% | 1,0 M € | +10.9% | 906,1 k € | +41.4% | 641,0 k € | +14.7% | 558,8 k € | +21.0% | 461,9 k € | +56.3% | 295,4 k € | |
| Cash | 153,6 k € | +99.3% | 77,1 k € | -75.2% | 311,1 k € | +2.0% | 304,9 k € | +41.3% | 215,8 k € | -53.7% | 466,3 k € | +28.2% | 363,8 k € | -39.8% | 604,9 k € | +14.8% | 527,0 k € | +153.0% | 208,3 k € | -33.8% | 314,6 k € | +6.9% | 294,2 k € | +30.8% | 224,9 k € | +47.3% | 152,7 k € | +33.1% | 114,8 k € | +18.0% | 97,2 k € | +456.5% | 17,5 k € | -71.1% | 60,4 k € | -14.9% | 71,0 k € | |
| Debts | 152,4 k € | +22.3% | 124,6 k € | -71.7% | 439,7 k € | +79.7% | 244,7 k € | +33.6% | 183,1 k € | -67.2% | 558,7 k € | -0.9% | 563,5 k € | +216.5% | 178,1 k € | -5.9% | 189,3 k € | -6.7% | 203,0 k € | -26.1% | 274,7 k € | -24.6% | 364,3 k € | -1.2% | 368,9 k € | -4.3% | 385,5 k € | +5.2% | 366,6 k € | +114.1% | 171,2 k € | +3.5% | 165,4 k € | +17.4% | 140,9 k € | +180.2% | 50,3 k € | |
Private limited company · Roeselare · incorporated on 27/01/2006
Private limited company profitable and well capitalised. Cash position rising (+99.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Remery is a Private limited company incorporated in 2006. Its main activity is: Other human health activities. Its registered office is in Roeselare.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette